Literature DB >> 6337438

Cyclosporin A tissue levels in a cadaveric renal allograft recipient.

B D Kahan, C T Van Buren, M Boileau, M Ried, W D Payne, S Flechner, J Newburger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6337438     DOI： 10.1097/00007890-198301000-00018

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  10 in total

Review 1.  The use of therapeutic drug monitoring to optimise immunosuppressive therapy.

Authors:  S M Tsunoda; F T Aweeka
Journal:  Clin Pharmacokinet       Date:  1996-02       Impact factor: 6.447

Review 2.  Complications of cyclosporin therapy.

Authors:  B D Kahan; S M Flechner; M I Lorber; C Jensen; D Golden; C T Van Buren
Journal:  World J Surg       Date:  1986-06       Impact factor: 3.352

3.  Concentrations of ciclosporin in allogeneic bone marrow recipients. Comparison of assay methods.

Authors:  P Sonneveld; E Kokenberg; W Sizoo; A Hagenbeek; K van der Steuijt; B Löwenberg
Journal:  Blut       Date:  1987-11

4.  Myofibroblast proliferation, fibrosis, and defective pancreatic repair induced by cyclosporin in rats.

Authors:  E Vaquero; X Molero; X Tian; A Salas; J R Malagelada
Journal:  Gut       Date:  1999-08       Impact factor: 23.059

5.  The effects of cyclosporin A on glucose homeostasis and the kidney in the normal rat.

Authors:  P H Whiting; K J Thomson; N J Saunders; J G Simpson
Journal:  J Exp Pathol (Oxford)       Date:  1990-04

6.  Blood and tissue distribution of cyclosporin A after a single oral dose in the rat.

Authors:  K Nooter; B Meershoek; W Spaans; P Sonneveld; R Oostrum; J Deurloo
Journal:  Experientia       Date:  1984-06-15

Review 7.  Clinical pharmacokinetics of cyclosporin.

Authors:  R J Ptachcinski; R Venkataramanan; G J Burckart
Journal:  Clin Pharmacokinet       Date:  1986 Mar-Apr       Impact factor: 6.447

8.  Long-term survival of donor-specific pancreatic islet xenografts in fully xenogeneic chimeras (WF rat----B10 mouse).

Authors:  Y J Zeng; C Ricordi; A Tzakis; H L Rilo; P B Carroll; T E Starzl; S T Ildstad
Journal:  Transplantation       Date:  1992-02       Impact factor: 4.939

9.  Interaction of immunosuppressants with HCV antivirals daclatasvir and asunaprevir: combined effects with mycophenolic acid.

Authors:  Petra E de Ruiter; Yashna Gadjradj; Robert J de Knegt; Herold J Metselaar; Jan Nm Ijzermans; Luc Jw van der Laan
Journal:  World J Transplant       Date:  2018-09-10

10.  Comparing Predictions of a PBPK Model for Cyclosporine With Drug Levels From Therapeutic Drug Monitoring.

Authors:  Sonja E Zapke; Stefan Willmann; Scott-Oliver Grebe; Kristin Menke; Petra A Thürmann; Sven Schmiedl
Journal:  Front Pharmacol       Date:  2021-05-14       Impact factor: 5.810
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.